Description
Myo-Inositol Trispyrophosphate (ITPP) Tablets
Myo-Inositol Trispyrophosphate (ITPP) is a phosphorylated derivative of inositol that has attracted attention for its potential therapeutic applications, particularly in enhancing oxygen delivery in tissues by modifying hemoglobin’s affinity for oxygen. It may also play a role in cancer research by inhibiting tumor growth through metabolic pathway modulation and has been studied for its neuroprotective effects in neurodegenerative conditions.
| Myo-Inositol Trispyrophosphate | |
| CAS Number | 623552-11-4 |
| Molar Mass | 605.984 g/mol |
| Chemical Formula | C6H12O21P6 |
| IUPAC Name | 4,6,11,13,18,20-hexahydroxy-3,5,7,10,12,14,17,19,21-nonaoxa-4λ5,6λ5,11λ5,13λ5,18λ5,20λ5-hexaphosphatetracyclo[14.5.0.02,8.09,15]henicosane 4,6,11,13,18,20-hexaoxide |
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
